APA

Hoster E., Geisler C. H., Doorduijn J., van der Holt B., Walewski J., Bloehdorn J., Ribrag V., Salles G., Hallek M., Pott C., Szymczyk M., Kolstad A., Laurell A., Räty R., Jerkeman M., Van't Veer M., Kluin-Nelemans J. C., Klapper W., Unterhalt M., Dreyling M. & Hermine O. (20180309). Total body irradiation after high-dose cytarabine in mantle cell lymphoma: a comparison of Nordic MCL2, HOVON-45, and European MCL Younger trials. : Leukemia.

Chicago

Hoster E, Geisler C H, Doorduijn J, van der Holt B, Walewski J, Bloehdorn J, Ribrag V, Salles G, Hallek M, Pott C, Szymczyk M, Kolstad A, Laurell A, Räty R, Jerkeman M, Van't Veer M, Kluin-Nelemans J C, Klapper W, Unterhalt M, Dreyling M and Hermine O. 20180309. Total body irradiation after high-dose cytarabine in mantle cell lymphoma: a comparison of Nordic MCL2, HOVON-45, and European MCL Younger trials. : Leukemia.

Harvard

Hoster E., Geisler C. H., Doorduijn J., van der Holt B., Walewski J., Bloehdorn J., Ribrag V., Salles G., Hallek M., Pott C., Szymczyk M., Kolstad A., Laurell A., Räty R., Jerkeman M., Van't Veer M., Kluin-Nelemans J. C., Klapper W., Unterhalt M., Dreyling M. and Hermine O. (20180309). Total body irradiation after high-dose cytarabine in mantle cell lymphoma: a comparison of Nordic MCL2, HOVON-45, and European MCL Younger trials. : Leukemia.

MLA

Hoster E, Geisler C H, Doorduijn J, van der Holt B, Walewski J, Bloehdorn J, Ribrag V, Salles G, Hallek M, Pott C, Szymczyk M, Kolstad A, Laurell A, Räty R, Jerkeman M, Van't Veer M, Kluin-Nelemans J C, Klapper W, Unterhalt M, Dreyling M and Hermine O. Total body irradiation after high-dose cytarabine in mantle cell lymphoma: a comparison of Nordic MCL2, HOVON-45, and European MCL Younger trials. : Leukemia. 20180309.